Three papers
by Rebecca A Clewell
published in 2020
- RA Clewell, JA Leonard, CI Nicolas, JL Campbell, M Yoon, AY Efremenko, PD McMullen, ME Andersen, HJ Clewell, KA Phillips, and YM Tan. Application of a combined aggregate exposure pathway and adverse outcome pathway (AEP-AOP) approach to inform a cumulative risk assessment: A case study with phthalates. Toxicol In Vitro 66 : 104855 (Aug 8, 2020). [abstract] [pubmed]
- PD McMullen, S Bhattacharya, CG Woods, SN Pendse, MT McBride, VY Soldatow, C Deisenroth, EL LeCluyse, RA Clewell, and ME Andersen. Identifying qualitative differences in PPARĪ± signaling networks in human and rat hepatocytes and their significance for next generation chemical risk assessment methods. Toxicol In Vitro 64 : 104463 (Apr 15, 2020). [abstract] [pubmed]
- T Beames, M Moreau, LA Roberts, K Mansouri, S Haider, M Smeltz, CI Nicolas, D Doheny, MB Phillips, M Yoon, RA Becker, PD McMullen, ME Andersen, RA Clewell, and JK Hartman. The role of fit-for-purpose assays within tiered testing approaches: A case study evaluating prioritized estrogen-active compounds in an in vitro human uterotrophic assay. Toxicol Appl Pharmacol 387 : 114774 (Jan 15, 2020). [abstract] [pubmed]